Cargando…
Characterization of novel biomarkers in selecting for subtype specific medulloblastoma phenotypes
Major research efforts have focused on defining cell surface marker profiles for characterization and selection of brain tumor stem/progenitor cells. Medulloblastoma is the most common primary malignant pediatric brain cancer and consists of 4 molecular subgroups: WNT, SHH, Group 3 and Group 4. Give...
Autores principales: | Liang, Lisa, Aiken, Christopher, McClelland, Robyn, Morrison, Ludivine Coudière, Tatari, Nazanin, Remke, Marc, Ramaswamy, Vijay, Issaivanan, Magimairajan, Ryken, Timothy, Del Bigio, Marc R., Taylor, Michael D., Werbowetski-Ogilvie, Tamra E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770744/ https://www.ncbi.nlm.nih.gov/pubmed/26497209 |
Ejemplares similares
-
OTX2 exhibits cell-context-dependent effects on cellular and molecular properties of human embryonic neural precursors and medulloblastoma cells
por: Kaur, Ravinder, et al.
Publicado: (2015) -
Characterization of a novel OTX2‐driven stem cell program in Group 3 and Group 4 medulloblastoma
por: Stromecki, Margaret, et al.
Publicado: (2018) -
Cross-species analysis of SHH medulloblastoma models reveals significant inhibitory effects of trametinib on tumor progression
por: Borlase, Stephanie, et al.
Publicado: (2023) -
An OTX2-PAX3 signaling axis regulates Group 3 medulloblastoma cell fate
por: Zagozewski, Jamie, et al.
Publicado: (2020) -
Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression
por: Zagozewski, Jamie, et al.
Publicado: (2022)